InspireMD Provides Amended Disclosure – Nasdaq

By /

InspireMD Provides Amended Disclosure Nasdaq

TEL AVIV, Israel, March 22, 2019– InspireMD, Inc., developer of the CGuard™ Embolic Prevention System for the prevention of stroke caused by the.

About The Author

Scroll to Top